167 related articles for article (PubMed ID: 25005574)
1. Long-term cognitive function change among breast cancer survivors.
Zheng Y; Luo J; Bao P; Cai H; Hong Z; Ding D; Jackson JC; Shu XO; Dai Q
Breast Cancer Res Treat; 2014 Aug; 146(3):599-609. PubMed ID: 25005574
[TBL] [Abstract][Full Text] [Related]
2. Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: the role of encoding versus forgetting.
Root JC; Andreotti C; Tsu L; Ellmore TM; Ahles TA
J Cancer Surviv; 2016 Jun; 10(3):593-9. PubMed ID: 26658913
[TBL] [Abstract][Full Text] [Related]
3. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors.
Kesler S; Hadi Hosseini SM; Heckler C; Janelsins M; Palesh O; Mustian K; Morrow G
Clin Breast Cancer; 2013 Aug; 13(4):299-306. PubMed ID: 23647804
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
5. Speed of processing training in middle-aged and older breast cancer survivors (SOAR): results of a randomized controlled pilot.
Meneses K; Benz R; Bail JR; Vo JB; Triebel K; Fazeli P; Frank J; Vance DE
Breast Cancer Res Treat; 2018 Feb; 168(1):259-267. PubMed ID: 29128897
[TBL] [Abstract][Full Text] [Related]
6. Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors.
Huang Z; Zheng Y; Bao P; Cai H; Hong Z; Ding D; Jackson J; Shu XO; Dai Q
Oncotarget; 2017 Feb; 8(7):12364-12373. PubMed ID: 27738306
[TBL] [Abstract][Full Text] [Related]
7. Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion.
Hartman SJ; Natarajan L; Palmer BW; Parker B; Patterson RE; Sears DD
Contemp Clin Trials; 2015 Nov; 45(Pt B):371-376. PubMed ID: 26427563
[TBL] [Abstract][Full Text] [Related]
8. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
Von Ah D; Tallman EF
J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
10. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
[TBL] [Abstract][Full Text] [Related]
12. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
Prokasheva S; Faran Y; Cwikel J; Geffen DB
J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
[TBL] [Abstract][Full Text] [Related]
13. Associations of dietary intake and supplement use with post-therapy cognitive recovery in breast cancer survivors.
Huang Z; Shi Y; Bao P; Cai H; Hong Z; Ding D; Jackson J; Shu XO; Dai Q
Breast Cancer Res Treat; 2018 Aug; 171(1):189-198. PubMed ID: 29744676
[TBL] [Abstract][Full Text] [Related]
14. Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.
Apple AC; Ryals AJ; Alpert KI; Wagner LI; Shih PA; Dokucu M; Cella D; Penedo FJ; Voss JL; Wang L
Neuroimage Clin; 2017; 14():685-691. PubMed ID: 28377882
[TBL] [Abstract][Full Text] [Related]
15. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
16. Cognitive-behavioral management of chemotherapy-related cognitive change.
Ferguson RJ; Ahles TA; Saykin AJ; McDonald BC; Furstenberg CT; Cole BF; Mott LA
Psychooncology; 2007 Aug; 16(8):772-7. PubMed ID: 17152119
[TBL] [Abstract][Full Text] [Related]
17. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
[TBL] [Abstract][Full Text] [Related]
18. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
20. Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.
Schmidt ME; Chang-Claude J; Vrieling A; Heinz J; Flesch-Janys D; Steindorf K
J Cancer Surviv; 2012 Mar; 6(1):11-9. PubMed ID: 22160661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
